Bastiaan Privé is a radiation oncology resident at Erasmus MC and a postdoctoral researcher in nuclear medicine at Radboudumc, where he also completed his PhD. His current research focuses on theranostics in prostate cancer, with an emphasis on PSMA imaging and therapy in earlier stages of the disease. Recently, Bastiaan was invited to present the results of the BULLSEYE trial at the ASCO in Chicago.